5,6-dimethyl-N-(3-morpholinopropyl)benzo[d]thiazol-2-amine, 95.0%, 250mg

2-(4-Hydroxyphenoxy)acetonitrile, 98%, 1g

Quinazoline-2,4-diamine, 95.0%, 1g

2-(Aminomethyl)imidazo[1,2-a]pyridine-6-carbonitrile dihydrochloride, 96%, 100mg

2-((tert-Butoxycarbonyl)amino)-2-(3,5-dichlorophenyl)acetic acid, 95%, 1g

Ethyl 5-bromopyrazolo[1,5-a]pyrimidine-3-carboxylate, 95.0%, 5g

4-(4-Cyanobenzoyl)-2-methylpyridine, 97.0%, 1g

3-(3-Fluorophenyl)-1H-pyrazole-4-carbaldehyde, 97.0%, 25g

anti-Vimentin mouse monoclonal, VIM 3B4, 1 ml

4-(furan-2-yl)-6-[4-(propan-2-yl)phenyl]pyrimidin-2-amine, 95.0%, 2g

Dimethyl 3-methylglutarate, 95.0%, 5g

(S)-3-(tert-Butoxycarbonyl)thiazolidine-2-carboxylic acid, 95.0%, 250mg

2-(6-Chloro-1H-indol-3-yl)acetic acid, 95.0%, 1g